SC
SRDX

Sagefield Capital’s Surmodics SRDX Stock Holding History

Sagefield Capital’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-55,900
Closed -$2.35M – 108
2024
Q2 		$2.35M Buy
+55,900
New +$1.91M 0.25% 62

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sagefield Capital's SRDX Position: Q3 2024 in Review

Sagefield Capital sold out of Surmodics (SRDX) in Q3 2024, closing a stake of 55,900 shares — an estimated $2.35M sold.

Sagefield Capital first reported a position in SRDX in Q2 2024 and held it in 1 quarter. The position peaked at $2.35M in Q2 2024. 126 funds tracked by Wall St. Rank hold SRDX as of Q3 2024.

  • Sagefield Capital reported no remaining Surmodics position as of Q3 2024 after selling out during the quarter.
  • Sagefield Capital sold 55,900 Surmodics shares in Q3 2024, an estimated $2.35M.
  • Sagefield Capital first reported a position in Surmodics in Q2 2024 and held it in 1 quarter.
  • Sagefield Capital's Surmodics position peaked at $2.35M in Q2 2024.
  • 126 funds tracked by Wall St. Rank held Surmodics as of Q3 2024.

Based on Sagefield Capital's 13F filing for Q3 2024, filed 14 Nov 2024.